Ex situ heart perfusion: a novel model for drug validation and translation
Ex situ heart perfusion (ESHP) was first developed in the 19th century by the German physician Oskar Langendorff. In recent years, ESHP has been critical to the development of donation after circulatory determination of death (DCD) programmes around the globe. ESHP has potential uses that extend far...
Сохранить в:
| Главные авторы: | , , , , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Frontiers Media S.A.
2026-06-01
|
| Серии: | Frontiers in Cardiovascular Medicine |
| Предметы: | |
| Online-ссылка: | https://www.frontiersin.org/articles/10.3389/fcvm.2026.1790308/full |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|